Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: Evidence from activated microglial cells in vitro

Neurobiology of Disease

Volumn 14, Issue 3, 2003, Pages 417-424

  Wilms, H ^a   Claasen, J ^a   Rohl C ^a   Sievers, J ^a   Deuschl, G ^a   Lucius, R ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Microglia; Nitric oxide; Peripheral benzodiazepine binding receptor; Tumor necrosis factor

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CLONAZEPAM; DIAZEPAM; MIDAZOLAM; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG BINDING; DRUG INHIBITION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0348109489     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.07.002     Document Type: Article

References (52)

1. Alho H., Costa E., et al. Diazepam-binding inhibitor a neuropeptide located in selected neuronal populations of rat brain . Science. 229:(4709):1985;179-182.
2. 3H]PK 11195 binding autoradiography . Exp. Neurol. 109:(3):1990;333-341.
3. Amri H., Ogwuegbu S.O., et al. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology. 137:(12):1996;5707-5718.
4. Anholt R.R., Pedersen P.L., et al. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261:(2):1986;576-583.
5. Antkiewicz-Michaluk L., Mukhin A.G., et al. Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites. J. Biol. Chem. 263:(33):1988;17317-17321.
6. Banati R.B. Visualising microglial activation in vivo. Glia. 40:(2):2002;206-217.
7. Banati R.B., Gehrmann J., et al. Cytotoxicity of microglia. Glia. 7:(1):1993;111-118.
8. 3H]PK11195 binding to activated microglia . J. Neurocytol. 26:(2):1997;77-82.
9. Banati R.B., Newcombe J., et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis quantitative in vivo imaging of microglia as a measure of disease activity . Brain. 123:(11):2000;2321-23237.
10. Basile A.S., Klein D.C., et al. Characterization of benzodiazepine receptors in the bovine pineal gland evidence for the presence of an atypical binding site . Brain Res. 387:(2):1986;127-135.
11. Benavides J., Fage D., et al. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 421:(1-2):1987;167-172.
12. 3H]PK 11195 and autoradiographic localization . Arch. Int. Pharmacodyn. Ther. 266:(1):1983;38-49.
13. Black K.L., Ikezaki K., et al. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer. 65:(1):1990;93-97.
14. Boka G., Anglade P., et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172:(1-2):1994;151-154.
15. Boujrad N., Hudson J.R. Jr., et al. Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. Proc. Natl. Acad. Sci. USA. 90:(12):1993;5728-57231.
16. 3H)diazepam binding. Proc. Natl. Acad. Sci. USA. 74:(9):1977;3805-3809.
17. Cagnin A., Brooks D.J., et al. In-vivo measurement of activated microglia in dementia. Lancet. 358:(9280):2001;461-467.
18. Camins A., Diez-Fernandez C., et al. A new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands. Eur. J. Pharmacol. 272:(2-3):1995;289-292.
19. Corda M.G., Ferrari M., et al. Isolation, purification and partial sequence of a neuropeptide (diazepam-binding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition site. Neurosci. Lett. 47:(3):1984;319-324.
20. De Souza E.B., Anholt R.R., et al. Peripheral-type benzodiazepine receptors in endocrine organs autoradiographic localization in rat pituitary, adrenal, and testis . Endocrinology. 116:(2):1985;567-573.
21. DeLorey T.M., Olsen R.W. Gamma-aminobutyric acidA receptor structure and function. J. Biol. Chem. 267:(24):1992;16747-16750.
22. Ferrarese C., Appollonio I., et al. Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors. Ann. Neurol. 26:(4):1989;564-568.
23. Gebicke-Haerter P.J., Bauer J., et al. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J. Neurosci. 9:(1):1989;183-194.
24. Giegerich R., Meyer F., et al. GeneFisher - software support for the detection of postulated genes. Proc. Int. Conf. Intell. Syst. Mol. Biol. 4:1996;68-77.
25. Giulian D., Baker T.J. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6:(8):1986;2163-2178.
26. Ikezaki K., Black K.L. Stimulation of cell growth and DNA synthesis by peripheral benzodiazepine. Cancer Lett. 49:(2):1990;115-120.
27. Itzhak Y., Baker L., et al. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes evidence for multiplicity . Glia. 9:(3):1993;211-218.
28. Kreutzberg G.W. Microglia a sensor for pathological events in the CNS . Trends Neurosci. 19:(8):1996;312-318.
29. Kuhlmann A.C., Guilarte T.R. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J. Neurochem. 74:(4):2000;1694-1704.
30. Lacor P., Benavides J., et al. Enhanced expression of the peripheral benzodiazepine receptor (PBR) and its endogenous ligand octadecaneuropeptide (ODN) in the regenerating adult rat sciatic nerve. Neurosci. Lett. 220:(1):1996;61-65.
31. Lacor P., Gandolfo P., et al. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration a role for PBR in neurosteroidogenesis . Brain Res. 815:(1):1999;70-80.
32. Lenfant M., Haumont J., et al. In vivo immunomodulating activity of PK 1195, a structurally unrelated ligand for "peripheral" benzodiazepine binding sites. I. Potentiation in mice of the humoral response to sheep red blood cells. Int. J. Immunopharmacol. 8:(7):1986;825-828.
33. Lokensgard J.R., Chao C.C., et al. Benzodiazepines, glia, and HIV-1 neuropathogenesis. Mol. Neurobiol. 18:(1):1998;23-33.
34. McEnery M.W., Snowman A.M., et al. Isolation of the mitochondrial benzodiazepine receptor association with the voltage-dependent anion channel and the adenine nucleotide carrier . Proc. Natl. Acad. Sci. USA. 89:(8):1992;3170-3174.
35. Meda L., Cassatella M.A., et al. Activation of microglial cells by beta-amyloid protein and interferon- gamma. Nature. 374:(6523):1995;647-650.
36. Mihm M.J., Schanbacher B.L., et al. Free 3-nitrotyrosine causes striatal neurodegeneration in vivo. J. Neurosci. 21:(11):2001;RC149.
37. Olson J.M., Ciliax B.J., et al. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 152:(1-2):1988;47-53.
38. Papadopoulos V., Mukhin A.G., et al. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265:(7):1990;3772-3779.
39. Park, C. H., Carboni, E. et al., 1996. Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 16 (1)1, 65-70.
40. Patte C., Gandolfo P., et al. GABA inhibits endozepine release from cultured rat astrocytes. Glia. 25:(4):1999;404-411.
41. Pedigo N.W., Schoemaker H., et al. Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney. Neurobiol. Aging. 2:(2):1981;83-88.
42. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II actions and mechanisms of action . Trends Neurosci. 18:(3):1995;130-136.
43. Schwartz-Bloom R.D., Miller K.A., et al. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia an ultrastructural study . Neuroscience. 98:(3):2000;471-484.
44. Sievers J., Parwaresch R., et al. Blood monocytes and spleen macrophages differentiate into microglia- like cells on monolayers of astrocytes morphology . Glia. 12:(4):1994;245-258.
45. Stephenson D.T., Schober D.A., et al. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 15:(7/2):1995;5263-5274.
46. Tallman J.F., Paul S.M., et al. Receptors for the age of anxiety pharmacology of the benzodiazepines . Science. 207:(4428):1980;274-281.
47. Vowinckel E., Reutens D., et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 50:(2):1997;345-353.
48. Wang J.K., Morgan J.I., et al. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. USA. 81:(3):1984;753-756.
49. Westenfelder C., Biddle D.L., et al. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 55:(3):1999;808-820.
50. Wilms H., Hartmann D., et al. Ramification of microglia, monocytes and macrophages in vitro influences of various epithelial and mesenchymal cells and their conditioned media . Cell Tissue Res. 287:(3):1997;447-458.
51. Wilms H., Wollmer M.A., et al. In vitro-staining specificity of the antibody 5-D-4 for microglia but not for monocytes and macrophages indicates that microglia are a unique subgroup of the myelomonocytic lineage. J. Neuroimmunol. 98:(2):1999;89-95.
52. Zavala F., Taupin V., et al. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J. Pharmacol. Exp. Ther. 255:(2):1990;442-450.